← Leaderboards
J Kevin Donahue
Univ Of Massachusetts Med Sch Worcester
$21,661,089
Attributed
$24,755,538
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,755,538 · 12
By mechanism
R01$17,864,612 · 7
R33$3,447,560 · 1
T32$2,322,588 · 1
R21$441,625 · 1
R61$418,750 · 1
R41$260,403 · 1
Top collaborators
- Catarina I Kiefe5 shared
- David D. Mcmanus3 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Mayra S. Tisminetzky$2,391,686
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyArrhythmiaGene TransferAtrial FibrillationAnti-Arrhythmia AgentsCessation Of LifeDeveloped CountriesProceduresHeart AtriumRefractoryTissuesPreventPharmacotherapyAblationGenesPotassium ChannelConnexin 43AffectFatigueRecording Of Previous EventsHealth Care CostsHeart RhythmCongestive Heart FailurePalpitations
Grant awards (45)
Translating post-infarct ventricular tachycardia mechanisms into a therapy$809,256
R01 · FY2025 · HL · contact PI
Transdisciplinary Training In Cardiovascular Research$427,639
T32 · FY2025 · HL
Translating post-infarct ventricular tachycardia mechanisms into a therapy$804,157
R01 · FY2024 · HL · contact PI
Calcium and MAPKinase Signaling and Structural Remodeling in Atrial Fibrillation$721,639
R01 · FY2024 · HL · contact PI
Transdisciplinary Training In Cardiovascular Research$358,994
T32 · FY2024 · HL
A phase I trial of AdKCNH2-G628S gene therapy for post-op atrial fibrillation$1,212,885
R33 · FY2023 · HL · contact PI
Calcium and MAPKinase Signaling and Structural Remodeling in Atrial Fibrillation$831,731
R01 · FY2023 · HL · contact PI
Translating post-infarct ventricular tachycardia mechanisms into a therapy$823,836
R01 · FY2023 · HL · contact PI
Transdisciplinary Training In Cardiovascular Research$508,310
T32 · FY2023 · HL
A phase I trial of AdKCNH2-G628S gene therapy for post-op atrial fibrillation$2,234,675
R33 · FY2022 · HL · contact PI
Calcium and MAPKinase Signaling and Structural Remodeling in Atrial Fibrillation$830,056
R01 · FY2022 · HL · contact PI
Transdisciplinary Training In Cardiovascular Research$494,192
T32 · FY2022 · HL
Calcium and MAPKinase Signaling and Structural Remodeling in Atrial Fibrillation$830,056
R01 · FY2021 · HL · contact PI
Transdisciplinary Training In Cardiovascular Research$533,453
T32 · FY2021 · HL
A phase I trial of AdKCNH2-G628S gene therapy for post-op atrial fibrillation$418,750
R61 · FY2021 · HL · contact PI
Integrative analysis of electrophysiology in the healed myocardial infarction scar$688,575
R01 · FY2020 · HL · contact PI
Final preclinical development of AAV gene therapy for atrial fibrillation$721,436
R01 · FY2019 · HL · contact PI
Integrative analysis of electrophysiology in the healed myocardial infarction scar$688,575
R01 · FY2019 · HL · contact PI
Final preclinical development of AAV gene therapy for atrial fibrillation$721,436
R01 · FY2018 · HL · contact PI
Integrative analysis of electrophysiology in the healed myocardial infarction scar$688,575
R01 · FY2018 · HL · contact PI
Catheter Development for Epicardial Atrial Gene Painting$260,403
R41 · FY2018 · TR · contact PI
Final preclinical development of AAV gene therapy for atrial fibrillation$721,436
R01 · FY2017 · HL · contact PI
Integrative analysis of electrophysiology in the healed myocardial infarction scar$705,450
R01 · FY2017 · HL · contact PI
Final preclinical development of AAV gene therapy for atrial fibrillation$721,436
R01 · FY2016 · HL · contact PI
Final preclinical development of gene therapy for post-operative atrial fibrillat$125,625
R21 · FY2014 · AG · contact PI
Preclinical gene therapy development for post-operative atrial fibrillation$316,000
R21 · FY2013 · AG · contact PI
GENE TRANSFER APPROACHES TO ATRIAL FIBRILATION$260,537
R01 · FY2012 · HL · contact PI
GENE TRANSFER APPROACHES TO ATRIAL FIBRILATION$128,038
R01 · FY2012 · HL · contact PI
Focal Modification of Electrical Conduction in the Heart$426,853
R01 · FY2011 · HL · contact PI
GENE TRANSFER APPROACHES TO ATRIAL FIBRILATION$392,500
R01 · FY2011 · HL · contact PI
Focal Modification of Electrical Conduction in the Heart$431,164
R01 · FY2010 · HL · contact PI
GENE TRANSFER APPROACHES TO ATRIAL FIBRILATION$392,500
R01 · FY2010 · HL · contact PI
Focal Modification of Electrical Conduction in the Heart$428,894
R01 · FY2009 · HL · contact PI
GENE TRANSFER APPROACHES TO ATRIAL FIBRILATION$392,500
R01 · FY2009 · HL · contact PI
Focal Modification of Electrical Conduction in the Heart$416,403
R01 · FY2008 · HL · contact PI
GENE TRANSFER APPROACHES TO ATRIAL FIBRILATION$392,500
R01 · FY2008 · HL · contact PI
Focal Modification of Electrical Conduction in the Heart$377,173
R01 · FY2006 · HL · contact PI
Focal Modification of Electrical Conduction in the Heart$408,750
R01 · FY2005 · HL
Improved Methods for Myocardial Gene Transfer$244,833
R01 · FY2005 · EB
Improved Methods for Myocardial Gene Transfer$49,467
R01 · FY2005 · EB
Focal Modification of Electrical Conduction in the Heart$408,750
R01 · FY2004 · HL
Improved Methods for Myocardial Gene Transfer$294,300
R01 · FY2004 · EB
Focal Modification of Electrical Conduction in the Heart$408,750
R01 · FY2003 · HL
Improved Methods for Myocardial Gene Transfer$294,300
R01 · FY2003 · EB
Focal Modification of Electrical Conduction in the Heart$408,750
R01 · FY2002 · HL